Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Medicina|October 13, 2020
[Acute ischemic stroke in cancer patients. A case-control study]Pedro E Colla Machado, Agustín Pappolla, Claudia Alonzo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 10, 2021
The frequency and characteristics of MS misdiagnosis in patients referred to the multiple sclerosis centre of CataloniaLuciana Midaglia, Jaume Sastre-Garriga, Agustín Pappolla, et al.
Multiple Sclerosis and Related Disorders|April 7, 2020
Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American populationFacundo Silveira, Agustín Pappolla, Francisco Sánchez, et al.
Multiple Sclerosis and Related Disorders|December 8, 2020
Usage trend of oral drugs for multiple sclerosis patients in ArgentinaRicardo Alonso, Orlando Garcea, María Barbara Eizaguirre, et al.
Multiple Sclerosis and Related Disorders|November 30, 2025
"Effectiveness and associated factors of response to Fampridine in multiple sclerosis: A prospective observational study from an expert center"Elisa Martinez-Campos, Miguel Angel Robles, Rosalia Horno, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 30, 2025
Radiologically isolated syndrome: How could we accurately diagnose a subclinical period of multiple sclerosis?Andreu Vilaseca, Angela Vidal-Jordana, Sofia Sceppacuercia, et al.
The Lancet Regional Health. Europe|April 28, 2025
The Barcelona baseline risk score to predict long-term prognosis after a first demyelinating event: a prospective observational studyCarmen Tur, Pere Carbonell-Mirabent, Susana Otero-Romero, et al.
European Journal of Neurology|July 16, 2025
The Variant rs7665090 Is Associated With Interferon-Beta Response in Multiple Sclerosis PatientsAndreu Vilaseca, Elena Urcelay, Sunny Malhotra, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 20, 2023
A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patientsRené Carvajal, Carmen Tur, Xavier Martínez-Gómez, et al.
JAMA Network Open|April 12, 2024
Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With NatalizumabRené Carvajal, Ana Zabalza, Pere Carbonell-Mirabent, et al.
Pageof 5